PAR 3.23% 30.0¢ paradigm biopharmaceuticals limited..

Valuation and Targets, page-323

  1. 1,048 Posts.
    lightbulb Created with Sketch. 531
    @dtcope invented "covid interruptus" on another thread in relation to DELAY
    I think it is CI.
    I suggest that DELAY is a fundamental aspect of valuation and price recovery, and here rather than 51capital is the right place to discuss.
    smile.png
    Our key market and presumably base for trials is USA, at the very least it is FDA, although there is an outside chane of something happening with TGA (but i am thinking 4Q or 1Q2021 now).
    So if you want a baseline for delay go to this site
    https://www.worldometers.info/coronavirus/
    scroll to Daily New Cases in the United States
    and wait until it flattens for a 14 day period and you know the minimum delay when that happens.
    Right now it looks to me like 10 weeks before it will drop from exponential to linear growth.
    SO If we are lucky maybe 20 weeks delay?
    IMO.
    yours?
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
30.0¢
Change
-0.010(3.23%)
Mkt cap ! $104.9M
Open High Low Value Volume
31.0¢ 31.5¢ 29.0¢ $161.3K 527.5K

Buyers (Bids)

No. Vol. Price($)
2 10756 30.0¢
 

Sellers (Offers)

Price($) Vol. No.
31.0¢ 62010 3
View Market Depth
Last trade - 16.10pm 15/07/2024 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.